F

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Associate Director/Director - Data Science, EHR AI

Applied Machine LearningConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A PhD in computer science, biomedical informatics, statistics, epidemiology, or a related quantitative field is required.
  • At least 5 years of industry or research experience building machine learning models on EHR data, including linked claims or other real-world data, with substantiated results such as peer-reviewed publications, deployed models, or externally validated performance.
  • At least 2 years of people management, leading data scientists or ML researchers as direct reports.
  • Working knowledge of how EHR and claims data are generated and structured, including encounters, diagnoses, procedures, medications, labs, vitals, clinical notes, coverage periods, and reimbursement records, as well as coding practices, missingness, and variation across sites, payers, and countries.
  • Fluency with clinical vocabularies and common data models, including ICD-10 and its national modifications, SNOMED CT, LOINC, RxNorm, ATC, procedure coding systems, and the OMOP CDM.
  • Familiarity with common uses of EHR data and real-world evidence in drug development, including phenotyping and cohort definition, trial feasibility and eligibility, natural history, outcome prediction, external control arms, comparative effectiveness, and safety signal detection.
  • Hands-on proficiency in Python and modern machine learning frameworks, with the ability to review code and run experiments.
  • High comfort with large language models, including coding agents, as part of daily work.
  • Strong communication skills with clinical, scientific, and executive audiences.

Responsibilities

  • Lead the EHR AI team within Data Science by setting technical strategy, hiring and developing the team, and owning delivery against portfolio priorities.
  • Build and validate predictive models on longitudinal EHR and claims data for disease progression, time-to-event outcomes, and patient-level treatment response, using evaluation designs that hold up under temporal and cross-site shift.
  • Evaluate, adapt, and fine-tune EHR foundation models for patient representation, and determine where they outperform simpler baselines.
  • Combine predictive modeling with causal approaches such as target trial emulation to identify approved drugs that modify disease course and generate repurposing and indication-expansion candidates.
  • Deliver fast, rigorous EHR and real-world evidence analyses for Business Development diligence and R&D programs, including cohort definition and feasibility, natural history, patient segmentation, and endpoint and trial design support.
  • Partner with Engineering and Product to turn prototypes into reusable, self-serve capabilities, and work with data partners on dataset selection and fitness for use.
  • Set standards for phenotype definition, validation, and reproducibility across EHR and real-world data work.

Desired Qualifications

  • Experience pretraining, fine-tuning, or rigorously benchmarking EHR foundation models or large-language-model-based approaches to patient timelines.
  • Causal inference on observational health data, including target trial emulation, propensity score methods, instrumental variables, doubly robust estimators, or machine-learning-based estimators.
  • Use of large language models for clinical text, such as phenotyping or information extraction from clinical notes.
  • Experience with OHDSI tools and network studies, or with large linked EHR and biobank resources such as All of Us or UK Biobank.
  • A track record of EHR models that influenced acquisition, licensing, trial design, or regulatory decisions.
  • Exposure to health economics and outcomes research (HEOR).

About the Company

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Formation Bio uses an AI-driven platform to speed up drug development by focusing on clinical-stage assets. It acquires and advances these assets using flexible financing structures, aiming to shorten timelines and cut costs for bringing new drugs to market. The core product is the proprietary AI tools that help with drug selection, development planning, and improving overall efficiency, enabling partnerships and successful commercialization with pharmaceutical and biotech companies. Compared with competitors, Formation Bio combines a data-powered approach with adaptable financing and asset acquisition strategies to move assets forward quickly and cost-effectively. The goal is to make treatments more accessible and affordable by accelerating development and enabling faster, more predictable commercialization through AI-enhanced decision making and flexible funding options.

Company size
51-200
Company stage
Series D
Total funding
$530.3M
Headquarters
New York City, New York
Founded
2013

Recently Posted Jobs

Explore more opportunities at Formation Bio

See more jobs